Cargando…

SAT-277 Re-Evaluation of the 17-Hydroxyprogesterone (17-OHP) Screening Threshold for Diagnosing Nonclassic Congenital Adrenal Hyperplasia (NCCAH) in the Era of Liquid Chromatography Tandem-Mass Spectrometry (LC-MS/MS)

Background: NCCAH is characterized by reduced 21-hydroxylase activity leading to elevations in adrenal androgens. It may be associated with an inadequate cortisol response to ACTH stimulation. Clinical diagnosis is problematic as signs and symptoms overlap with more common conditions such as prematu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chesover, Alexander, Millar, Heather, Adeli, Khosrow, Palmert, Mark, Hamilton, Jill
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Pediatric Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552204/ http://dx.doi.org/10.1210/js.2019-SAT-277

Ejemplares similares

Screening for Nonclassic Congenital Adrenal Hyperplasia in the Era of Liquid Chromatography-Tandem Mass Spectrometry
por: Chesover, Alexander D, et al.
Publicado: (2019)

Simultaneous quantitation of four androgens and 17‐hydroxyprogesterone in polycystic ovarian syndrome patients by LC‐MS/MS
por: Cao, Zheng, et al.
Publicado: (2020)

What Cut-off Value of 17-Hydroxyprogesterone Should Be an Indication to Perform a 250 µg Cosyntropin Stimulation Test When NCCAH Is Suspected? - a Retrospective Study
por: Domagala, Bartosz, et al.
Publicado: (2021)

SAT287 Clinical And Biochemical Characteristics In Female Adolescents Diagnosed With Non-classic Congenital Adrenal Hyperplasia (NCCAH)
por: Hayes Dorado, Juan Pablo, et al.
Publicado: (2023)

Study relationship between the value of 17-OHP and the value of testosterone in monitoring for congenital adrenal hyperplasia
por: Huong, Ngo Thi Thu, et al.
Publicado: (2013)

SAT-098 The Impact of 17-OHP Cutoffs Determination in a Public Newborn Screening Program for Congenital Adrenal Hyperplasia in Southern Brazil: A Three Years’ Experience
por: Kopacek, Cristiane, et al.
Publicado: (2020)

SAT-011 Quantification of Testosterone, Androstenedione and 17-Hydroxyprogesterone Collected Using Mitra®Micro Sampling Devices
por: Marshall, David, et al.
Publicado: (2019)

An integrated PK‐PD model for cortisol and the 17‐hydroxyprogesterone and androstenedione biomarkers in children with congenital adrenal hyperplasia
por: Al‐Kofahi, Mahmoud, et al.
Publicado: (2020)

Management of the Female With Non-classical Congenital Adrenal Hyperplasia (NCCAH): A Patient-Oriented Approach
por: Livadas, Sarantis, et al.
Publicado: (2019)

A pilot study on the effect of three hydrocortisone dosing regimen on 17 hydroxyprogesterone levels in patients with congenital adrenal hyperplasia
por: Salud, Josephine Leiya Marie F, et al.
Publicado: (2013)

SUN-037 Discordant Serum 17-hydroxyprogesterone and Androstenedione in the Management of Congenital Adrenal Hyperplasia: Are 11-oxygenated Androgens Useful?
por: Jha, Smita, et al.
Publicado: (2020)

Diurnal salivary androstenedione and 17‐hydroxyprogesterone levels in healthy volunteers for monitoring treatment efficacy of patients with congenital adrenal hyperplasia
por: Adriaansen, Bas P. H., et al.
Publicado: (2022)

Functional effects of 17alpha-hydroxyprogesterone caproate (17P) on human myometrial contractility in vitro
por: Sexton, Donal J, et al.
Publicado: (2004)

The Influence of Prior Obstetrical History on Current 17-Hydroxyprogesterone Caproate Use
por: Ransom, Carla E., et al.
Publicado: (2011)

An unusual cause of adrenal insufficiency with elevation of 17-hydroxyprogesterone: case report
por: Teti, Claudia, et al.
Publicado: (2023)

A 4-hour Profile of 17-hydroxyprogesterone in Salt-wasting Congenital Adrenal Hyperplasia: Is the Serial Monitoring Strategy Worth the Effort?
por: Besci, Özge, et al.
Publicado: (2022)

Model-Informed Target Morning 17α-Hydroxyprogesterone Concentrations in Dried Blood Spots for Pediatric Congenital Adrenal Hyperplasia Patients
por: Stachanow, Viktoria, et al.
Publicado: (2023)

Children with premature pubarche: is an alterated neonatal 17-Ohp screening test a predictive factor?
por: Cavarzere, Paolo, et al.
Publicado: (2018)

SAT-012 Urinary Aldosterone Assay Using LC-MS/MS Could Improve Primary Aldosteronism Screening
por: Travers, Simon, et al.
Publicado: (2019)

Nonclassic Congenital Adrenal Hyperplasia
por: Witchel, Selma Feldman, et al.
Publicado: (2010)

First Morning Pregnanetriol and 17-Hydroxyprogesterone Correlated Significantly in 21-Hydroxylase Deficiency
por: Itonaga, Tomoyo, et al.
Publicado: (2022)

Comparison of oral Dydrogesterone and 17-α hydroxyprogesterone caprate in the prevention of preterm birth
por: Alizadeh, Fahimeh, et al.
Publicado: (2022)

LC, MS(n) and LC–MS/MS studies for the characterization of degradation products of amlodipine
por: Tiwari, Ravi N., et al.
Publicado: (2015)

Validation of a Rapid and Sensitive LC-MS/MS Method for Determination of Exemestane and Its Metabolites, 17β-Hydroxyexemestane and 17β-Hydroxyexemestane-17-O-β-D-Glucuronide: Application to Human Pharmacokinetics Study
por: Wang, Ling-Zhi, et al.
Publicado: (2015)

SAT-004 The Development And Application Of An Lc-ms/ms Method To Investigate The Stability Of 11β-hydroxyandrostenedione And 11-ketotestosterone.
por: Hawley, James
Publicado: (2019)

Multiple 17-OHP Cutoff Co-Variates Fail to Improve 21-Hydroxylase Deficiency Screening Accuracy
por: Matharu, Preet K., et al.
Publicado: (2022)

Simultaneous quantitation of 17 endogenous adrenal corticosteroid hormones in human plasma by UHPLC-MS/MS and their application in congenital adrenal hyperplasia screening
por: Zhang, Qiaoxuan, et al.
Publicado: (2022)

Fecal metabolite analysis of Japanese macaques in Yakushima by LC-MS/MS and LC-QTOF-MS
por: TSUCHIDA, Sayaka, et al.
Publicado: (2021)

Can 17 hydroxyprogesterone caproate (17P) decrease preterm deliveries in patients with a history of PMC or pPROM?
por: Cohen, Gal, et al.
Publicado: (2022)

Nonclassical Congenital Adrenal Hyperplasia and Pregnancy
por: Cuhaci, Neslihan, et al.
Publicado: (2015)

Quantification of 17-desacetyl norgestimate in human plasma by liquid chromatography–tandem mass spectrometry (LC–MS/MS) and its application to bioequivalence study
por: Saxena, Ashish, et al.
Publicado: (2015)

SAT-355 Comparison of Two Serum Cortisol Immunoassays versus Liquid Chromatography: Tandem Mass Spectrometry (LC-MS/MS)
por: Brito, Luciana, et al.
Publicado: (2019)

SAT-LB70 Relationship Between LC-MS/MS Measurements of PTHrP and Calcium in Patients With Compromised Renal Function
por: Kroner, Grace, et al.
Publicado: (2020)

Largazole Pharmacokinetics in Rats by LC-MS/MS
por: Yu, Mingming, et al.
Publicado: (2014)

Application of LC–MS/MS in the Mycotoxins Studies
por: Gámiz-Gracia, Laura, et al.
Publicado: (2020)

Comparison of Flow Injection-MS/MS and LC-MS/MS for the Determination of Ochratoxin A
por: Zhang, Kai
Publicado: (2021)

The impact of neonatal 17-hydroxyprogesterone cutoff determination in a public newborn screening program for congenital adrenal hyperplasia in Southern Brazil: 3 years’ experience
por: de Castro, Simone Martins, et al.
Publicado: (2023)

LC and LC–MS/MS studies for the identification and characterization of degradation products of acebutolol
por: Rakibe, Uday, et al.
Publicado: (2018)

SAT-277 A Fierce Presentation of Cushing Disease
por: Al Sabie, Farah Laith, et al.
Publicado: (2020)

SAT-360 Acute Stress Increases Local Corticosterone Levels In Lymphoid Organs Of Neonatal Mice: Analysis Using LC-MS/MS
por: Hamden, Jordan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ksrk9d8v4fos27jjo0hkr6nnbs